The 4-T study of intensified insulin regimens shows excellent three-year glucose control
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
Amgen's Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent
- Details
- Category: Amgen
![Amgen Amgen](http://www.worldpharmanews.com/images/stories/logo/amgen.gif)
Pfizer Reports Third-Quarter 2009 Results
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Novartis drug Tasigna® meets primary endpoint in pivotal trial against Glivec®
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
- First registration study using molecular response as key indicator of patient outcomes; Bcr-Abl biomarker test measures very low levels of residual disease[1],[2]
Abbott Completes Visiogen Acquisition
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline (GSK) GlaxoSmithKline (GSK)](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
FDA approves Micardis® (telmisartan) as the first treatment in its class
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
More Pharma News ...
- FDA Approves CRESTOR for Use in Pediatric Patients with Heterozygous Familial Hypercholesterolemia
- Pfizer And Wyeth Become One: Working Together For A Healthier Worldâ¢
- Pfizer Completes Acquisition Of Wyeth
- GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
- Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau
- Expert Panel Offers Three-Step Plan to Guide People Toward Recovery of Depression
- Abbott Reports 16.5 Percent Earnings Growth in Third Quarter